Our findings imply that during normal physiological conditions, ASCT1 may influence the synaptic actions of glutamate, and, during pathological conditions, it may be involved in the aetiology of a range of neurological disorders including traumatic brain injury, Alzheimer’s disease, neuropathic pain, and schizophrenia. This evidence concerns the gene SLC1A4 and schizophrenia.